PAREXEL International Corporation (PRXL) Hits New 52-week Low During February 09 Session

Equities Staff |

PAREXEL International Corporation (PRXL) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $56.62, PAREXEL International Corporation dropped to $56.00 for a new 52-week low. By the closing bell, the company's stock was at $58.79 a share for a gain of 2.37%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

PAREXEL International Corporation saw 422,777 shares of its stock trade hands, that's out of 53.69 million shares outstand. The stock has an average daily volume of 635,473 shares. After hitting a new 52-week low, PAREXEL International Corporation enters the new trading day with a market cap of 3.16 billion, a 50-day SMA of $65.44 and a 200-day SMA of $66.12

PAREXEL International Corporation now has a P/E ratio of 23.3.

For a complete fundamental analysis analysis of PAREXEL International Corporation, check out’s Stock Valuation Analysis report for PRXL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

Parexel International Corp is a biopharmaceutical services company. The Company offers clinical research, clinical logistics, medical communications, and technology products and services to the pharmaceutical, biotechnology, and medical device industries.

PAREXEL International Corporation has 18,660 employees, is led by CEO Josef H. Von Rickenbach, and makes its home in Waltham, MA.

PAREXEL International Corporation is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.